Comparisons of antidiabetic treatments showed that men with T2D tended to have a lower frequency of metformin use, while the use of insulin, secretagogues, TZDs, AGIs, DPP-4Is, SGLT-2Is and GLP-1RAs was comparable. This evidence concerns the gene INS and type 2 diabetes mellitus.